Industrial Biotechnology is the use of natural processes - primarily of enzymes - for industrial manufacturing. It is also known as "white" biotechnology, in distinction from "red" biotechnology, which is devoted to medical and pharmaceutical purposes, and "green" biotechnology, or the application of biotechnology in agriculture.
Based on the use of enzymes, the white biotechnology industry manufactures products with a market value in excess of EUR 100 billion. The industry shows growth rates of 10 percent annually. EUCODIS Bioscience serves this market by providing novel and customized enzymes that perform to customers' challenging specific requirements.
White biotechnology is considered a key technology of the 21st century, as it offers economical and environmental advantages over traditional chemistry:
Lower Energy Costs
Enzymes enable chemical reactions at "biological" temperature, as opposed to high temperatures often required in traditional chemistry, significantly reducing energy costs.
Replacing Complex Synthesis
Enzymes permit the manufacture of chiral compounds and other difficult-to-synthesize intermediates, e.g. for the the production of active pharmaceutical ingredients (APIs). Customized enzymes help the chemical industry replace complex synthesis steps by a single biocatalytic step, making their products and processes more competitive.
Enzymes play a key role in efforts underway in Europe and the United States to exploit biomass as a feedstock for the production of high-value bioproducts, biofuels, and bioenergy from renewable resources. Making biomass an alternative to petroleum benefits the environment, spurs economic growth, and reduces the reliance on petroleum imports.